# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-19-000077
Filing Date
2019-05-09
Accepted
2019-05-09 16:04:23
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20190331.htm iXBRL | 10-Q | 1264475
2 | EX-31.1 | lgnd33119exhibit311.htm | EX-31.1 | 20927
3 | EX-31.2 | lgnd33119exhibit312.htm | EX-31.2 | 21257
4 | EX-32 | lgnd33119exhibit321.htm | EX-32.1 | 15609
10 | LOGO | lgnd-20190331_g1.jpg | GRAPHIC | 11735
| Complete submission text file | 0000886163-19-000077.txt |  | 6379366

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20190331.xsd | EX-101.SCH | 38874
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20190331_cal.xml | EX-101.CAL | 101269
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20190331_def.xml | EX-101.DEF | 219588
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20190331_lab.xml | EX-101.LAB | 557418
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20190331_pre.xml | EX-101.PRE | 360006
11 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20190331_htm.xml | XML | 1146528

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 19810438
SIC: 2834 Pharmaceutical Preparations